{"id":"1072","presentation":"HYPERPROGRESSIVE DISEASE IN A NSCLC PATIENT AFTER ANTI-PD-L1 ANTIBODY THERAPY DESPITE TO GOOD RESPONSE OF ANTI- PD-1 ANTIBODY WITH TEMPORARY INTERRUPTION DUE TO IRAE.","session":"AS16 - Lung Cancer","filename":"2020 chest congress final.pptx","speaker":"Chigusa Shirakawa","photo":"","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-presentations\/wchest20\/1072\/jpg\/2020chestcongressfinal\/thumbnails\/0.png","html5":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-presentations\/wchest20\/1072\/html\/2020chestcongressfinal\/data\/","what":"html5","code":"","priority":["html5","pdf","jpg","thumbnail"]}
[speaker]
[presentation]
[session]